• FirefoxInstall the new Firefox »
  •  Dow Down0.47% Nasdaq Down0.56%

    Amicus Therapeutics, Inc. (FOLD)

    -NasdaqGM
    8.48 Up 0.03(0.36%) Mar 3, 4:00PM EST
    |After Hours : 8.46 Down 0.02 (0.24%) Mar 3, 6:46PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 293   475   456   324  
    Cost of Revenue -   -   -   -  
    Gross Profit 293   475   456   324  
    Operating Expenses
    Research Development12,049  9,978  9,992  9,120  
    Selling General and Administrative4,670  4,448  5,681  4,605  
    Non Recurring15  (81)(8)1,988  
    Others375  396  412  401  
    Total Operating Expenses17,109  14,741  16,077  16,114  
    Operating Income or Loss (16,816) (14,266) (15,621) (15,790)
    Income from Continuing Operations
    Total Other Income/Expenses Net44  26  33  61  
    Earnings Before Interest And Taxes(16,772)(14,240)(15,588)(15,729)
    Interest Expense377  374  355  20  
    Income Before Tax(17,149)(14,614)(15,943)(15,749)
    Income Tax Expense -   -   -  (3,512)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(17,149)(14,614)(15,943)(12,237)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (17,149) (14,614) (15,943) (12,237)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (17,149) (14,614) (15,943) (12,237)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.